On Monday, President Donald Trump, Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., and other Trump administration officials announced a pair of actions the Food and Drug Administration (FDA) will take to address the increase in autism spectrum disorder (ASD) in children. First, the FDA will update the warning labels for acetaminophen — the active ingredient in pain relievers like Tylenol — to note a potential association between the ingredient and neurological conditions — such as ASD and attention-deficit/hyperactivity disorder (ADHD) — in children (though it also emphasized that no causal link has been established). Second, the agency has initiated the approval of leucovorin calcium tablets for patients with cerebral folate deficiency (CFD).
Ad-free podcasts are here!
To listen to this podcast ad-free, and to enjoy our subscriber only premium content, go to ReadTangle.com to sign up!
You can read today's podcast here, our “Under the Radar” story here and today’s “Have a nice day” story here.
You can subscribe to Tangle by clicking here or drop something in our tip jar by clicking here.
Take the survey: What do you think about the HHS announcement, autism, and Tylenol? Let us know.
Disagree? That's okay. My opinion is just one of many. Write in and let us know why, and we'll consider publishing your feedback.
Our Executive Editor and Founder is Isaac Saul. Our Executive Producer is Jon Lall.
This podcast was written by Ari Weitzman and edited and engineered by Dewey Thomas. Music for the podcast was produced by Diet 75.
Our newsletter is edited by Managing Editor Ari Weitzman, Senior Editor Will Kaback, Lindsey Knuth, Kendall White, Bailey Saul, and Audrey Moorehead.
Hosted on Acast. See acast.com/privacy for more information.
